Selective inhibition of arachidonic acid epoxidation in vivo

E. Brand-Schieber, J R Falck, M. Schwartzman

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Cytochrome P450 (CYP)-derived arachidonic acid metabolites, including epoxyeicosatrienoic acids (EETS) and 20-HETE, have been implicated in the regulation of renal function and vascular tone. Studying the function of specific CYP arachidonate metabolites has been hampered due to lack of selective inhibitors and difficulty in their solubilization. We have identified MS-PPOH as a potent and selective inhibitor of CYP-catalyzed arachidonate epoxidation in vitro. We used 2-hydroxypropyl-β-cyclodextrin as a vehicle in order to administer MS-PPOH in vivo. One hour after administration, MS-PPOH (5 mg, IV bolus) significantly inhibited arachidonic acid epoxidation in rat renal cortical microsomes (vehicle-282±12 pmol/mg/min, MS-PPOH-206±10 pmol/mg/min, p < 0.05) but had no effect on 20-HETE formation (vehicle-383±32 pmol/mg/min, MS-PPOH-367±9 pmol/mg/min). The inhibitory effect lasts at least for 6 hours. There was no inhibition of 20-HETE synthesis at any time point. We also examined the effect of MS-PPOH on renal excretiry function. Three hours after MS-PPOH administration to anesthetized rats, urine flow rate became significantly higher (vehicle-275±16 μl/hour, MS-PPOH-406±44 μl/hour, p < 0.05). Sodium excretion rate was also significantly higher (vehicle-28.7±4 μmol/hour, MS-PPOH-63.3±10 gmol/hour, p < 0.05) but potassium excretion rate was not affected (vehicle-65.5±5 μmol/hour, MS-PPOH-79.2±2 μmol/hour). These results suggest that MS-PPOH may be useful as a selective inhibitor of CYP-catalyzed arachidonic acid epoxidation in vivo, and implicate EETs and anti-diuretic and anti-natriuretic in the regulation of renal function.

Original languageEnglish (US)
Pages (from-to)655-672
Number of pages18
JournalJournal of Physiology and Pharmacology
Volume51
Issue number4
StatePublished - 2000

Fingerprint

Arachidonic Acid
Cytochrome P-450 Enzyme System
Kidney
N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide
Cyclodextrins
Microsomes
Diuretics
Blood Vessels
Potassium
Sodium
Urine
Acids

Keywords

  • Cytochrome P
  • Epoxyeicosanoids
  • N-methylsulphonyl-6-(2-propargyloxyphenyl) hexanamide (MS-PPOH)
  • Renal function

ASJC Scopus subject areas

  • Pharmacology
  • Physiology

Cite this

Selective inhibition of arachidonic acid epoxidation in vivo. / Brand-Schieber, E.; Falck, J R; Schwartzman, M.

In: Journal of Physiology and Pharmacology, Vol. 51, No. 4, 2000, p. 655-672.

Research output: Contribution to journalArticle

Brand-Schieber, E, Falck, JR & Schwartzman, M 2000, 'Selective inhibition of arachidonic acid epoxidation in vivo', Journal of Physiology and Pharmacology, vol. 51, no. 4, pp. 655-672.
Brand-Schieber, E. ; Falck, J R ; Schwartzman, M. / Selective inhibition of arachidonic acid epoxidation in vivo. In: Journal of Physiology and Pharmacology. 2000 ; Vol. 51, No. 4. pp. 655-672.
@article{562655bc1ab6451db6e1bf44ddd2819e,
title = "Selective inhibition of arachidonic acid epoxidation in vivo",
abstract = "Cytochrome P450 (CYP)-derived arachidonic acid metabolites, including epoxyeicosatrienoic acids (EETS) and 20-HETE, have been implicated in the regulation of renal function and vascular tone. Studying the function of specific CYP arachidonate metabolites has been hampered due to lack of selective inhibitors and difficulty in their solubilization. We have identified MS-PPOH as a potent and selective inhibitor of CYP-catalyzed arachidonate epoxidation in vitro. We used 2-hydroxypropyl-β-cyclodextrin as a vehicle in order to administer MS-PPOH in vivo. One hour after administration, MS-PPOH (5 mg, IV bolus) significantly inhibited arachidonic acid epoxidation in rat renal cortical microsomes (vehicle-282±12 pmol/mg/min, MS-PPOH-206±10 pmol/mg/min, p < 0.05) but had no effect on 20-HETE formation (vehicle-383±32 pmol/mg/min, MS-PPOH-367±9 pmol/mg/min). The inhibitory effect lasts at least for 6 hours. There was no inhibition of 20-HETE synthesis at any time point. We also examined the effect of MS-PPOH on renal excretiry function. Three hours after MS-PPOH administration to anesthetized rats, urine flow rate became significantly higher (vehicle-275±16 μl/hour, MS-PPOH-406±44 μl/hour, p < 0.05). Sodium excretion rate was also significantly higher (vehicle-28.7±4 μmol/hour, MS-PPOH-63.3±10 gmol/hour, p < 0.05) but potassium excretion rate was not affected (vehicle-65.5±5 μmol/hour, MS-PPOH-79.2±2 μmol/hour). These results suggest that MS-PPOH may be useful as a selective inhibitor of CYP-catalyzed arachidonic acid epoxidation in vivo, and implicate EETs and anti-diuretic and anti-natriuretic in the regulation of renal function.",
keywords = "Cytochrome P, Epoxyeicosanoids, N-methylsulphonyl-6-(2-propargyloxyphenyl) hexanamide (MS-PPOH), Renal function",
author = "E. Brand-Schieber and Falck, {J R} and M. Schwartzman",
year = "2000",
language = "English (US)",
volume = "51",
pages = "655--672",
journal = "Journal of Physiology and Pharmacology",
issn = "0867-5910",
publisher = "Polish Physiological Society",
number = "4",

}

TY - JOUR

T1 - Selective inhibition of arachidonic acid epoxidation in vivo

AU - Brand-Schieber, E.

AU - Falck, J R

AU - Schwartzman, M.

PY - 2000

Y1 - 2000

N2 - Cytochrome P450 (CYP)-derived arachidonic acid metabolites, including epoxyeicosatrienoic acids (EETS) and 20-HETE, have been implicated in the regulation of renal function and vascular tone. Studying the function of specific CYP arachidonate metabolites has been hampered due to lack of selective inhibitors and difficulty in their solubilization. We have identified MS-PPOH as a potent and selective inhibitor of CYP-catalyzed arachidonate epoxidation in vitro. We used 2-hydroxypropyl-β-cyclodextrin as a vehicle in order to administer MS-PPOH in vivo. One hour after administration, MS-PPOH (5 mg, IV bolus) significantly inhibited arachidonic acid epoxidation in rat renal cortical microsomes (vehicle-282±12 pmol/mg/min, MS-PPOH-206±10 pmol/mg/min, p < 0.05) but had no effect on 20-HETE formation (vehicle-383±32 pmol/mg/min, MS-PPOH-367±9 pmol/mg/min). The inhibitory effect lasts at least for 6 hours. There was no inhibition of 20-HETE synthesis at any time point. We also examined the effect of MS-PPOH on renal excretiry function. Three hours after MS-PPOH administration to anesthetized rats, urine flow rate became significantly higher (vehicle-275±16 μl/hour, MS-PPOH-406±44 μl/hour, p < 0.05). Sodium excretion rate was also significantly higher (vehicle-28.7±4 μmol/hour, MS-PPOH-63.3±10 gmol/hour, p < 0.05) but potassium excretion rate was not affected (vehicle-65.5±5 μmol/hour, MS-PPOH-79.2±2 μmol/hour). These results suggest that MS-PPOH may be useful as a selective inhibitor of CYP-catalyzed arachidonic acid epoxidation in vivo, and implicate EETs and anti-diuretic and anti-natriuretic in the regulation of renal function.

AB - Cytochrome P450 (CYP)-derived arachidonic acid metabolites, including epoxyeicosatrienoic acids (EETS) and 20-HETE, have been implicated in the regulation of renal function and vascular tone. Studying the function of specific CYP arachidonate metabolites has been hampered due to lack of selective inhibitors and difficulty in their solubilization. We have identified MS-PPOH as a potent and selective inhibitor of CYP-catalyzed arachidonate epoxidation in vitro. We used 2-hydroxypropyl-β-cyclodextrin as a vehicle in order to administer MS-PPOH in vivo. One hour after administration, MS-PPOH (5 mg, IV bolus) significantly inhibited arachidonic acid epoxidation in rat renal cortical microsomes (vehicle-282±12 pmol/mg/min, MS-PPOH-206±10 pmol/mg/min, p < 0.05) but had no effect on 20-HETE formation (vehicle-383±32 pmol/mg/min, MS-PPOH-367±9 pmol/mg/min). The inhibitory effect lasts at least for 6 hours. There was no inhibition of 20-HETE synthesis at any time point. We also examined the effect of MS-PPOH on renal excretiry function. Three hours after MS-PPOH administration to anesthetized rats, urine flow rate became significantly higher (vehicle-275±16 μl/hour, MS-PPOH-406±44 μl/hour, p < 0.05). Sodium excretion rate was also significantly higher (vehicle-28.7±4 μmol/hour, MS-PPOH-63.3±10 gmol/hour, p < 0.05) but potassium excretion rate was not affected (vehicle-65.5±5 μmol/hour, MS-PPOH-79.2±2 μmol/hour). These results suggest that MS-PPOH may be useful as a selective inhibitor of CYP-catalyzed arachidonic acid epoxidation in vivo, and implicate EETs and anti-diuretic and anti-natriuretic in the regulation of renal function.

KW - Cytochrome P

KW - Epoxyeicosanoids

KW - N-methylsulphonyl-6-(2-propargyloxyphenyl) hexanamide (MS-PPOH)

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=0034519059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034519059&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 655

EP - 672

JO - Journal of Physiology and Pharmacology

JF - Journal of Physiology and Pharmacology

SN - 0867-5910

IS - 4

ER -